Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,531
New position
Shares Held
645
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,721
of 2,820 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Highland Investment Advisors LLC holds $1,060,734 across 14 Drug Manufacturers - General names. PFE ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,921 | $483,400 | |
| 2 | LLY |
ELI LILLY & Co
|
211 | $253,079 | |
| 3 | JNJ |
Johnson & Johnson
|
311 | $78,984 | |
| 4 | AZN |
Astrazeneca PLC
|
404 | $76,606 | |
| 5 | MRK |
Merck & Co., Inc.
|
562 | $72,217 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
770 | $44,367 | |
| 7 | NVS |
Novartis AG
|
161 | $25,231 | |
| 8 | PFE |
Pfizer Inc
This page
|
645 | $15,531 |
All Filings in PFE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,531 | 645 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||